Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
GC Biopharma Corp. clinical trials
Also known as Green Cross, GC Pharma.
Part of GC Corp. (Green Cross Holdings), which holds 50.06% as of 2024-12-31. Source
The registry lists 78 studies whose lead sponsor is GC Biopharma Corp.. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.
Keep track of what changes. Save the GC Biopharma Corp. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to GC Biopharma Corp..
- Green Cross Corporation63 studiesSame company
Something wrong?
- GC Biopharma Corp15 studiesSame company
Something wrong?
Focus areas
Conditions GC Biopharma Corp. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 78. Browse all 78 →
- Phase 2/3 Clinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or OlderNot yet recruitingNCT07883928Phase 2/3
Sponsor listed in the registry: GC Biopharma Corp
- A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 YearsRecruitingNCT07054099Phase 3
Sponsor listed in the registry: GC Biopharma Corp
- A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry DiseaseRecruitingNCT06858397Phase 1/2
Sponsor listed in the registry: GC Biopharma Corp
- A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy AdultsRecruitingNCT06997627Phase 1/2
Sponsor listed in the registry: GC Biopharma Corp
- A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.RecruitingNCT05686759Phase 3
Sponsor listed in the registry: GC Biopharma Corp
- Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella VaccinationRecruitingNCT05422508Phase 2
Sponsor listed in the registry: Green Cross Corporation
- Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)Active, not recruitingNCT06567769Phase 1
Sponsor listed in the registry: GC Biopharma Corp
- A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy AdultsActive, not recruitingNCT07728396Phase 1
Sponsor listed in the registry: GC Biopharma Corp
- An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)CompletedNCT07344376Phase 3
Sponsor listed in the registry: GC Biopharma Corp
- A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia PatientCompletedNCT05493631Phase 1
Sponsor listed in the registry: GC Biopharma Corp
- Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral ImmunodeficiencyActive, not recruitingNCT04565015Phase 3
Sponsor listed in the registry: GC Biopharma Corp
- Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational StudyActive, not recruitingNCT07084246
Sponsor listed in the registry: GC Biopharma Corp
- A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS ⅡActive, not recruitingNCT05422482Phase 1
Sponsor listed in the registry: GC Biopharma Corp
- A Study of GC1111 in Hunter Syndrom PatientsCompletedNCT03920540Phase 3
Sponsor listed in the registry: Green Cross Corporation
- A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed ConditionsStatus unknownNCT05729386Phase 1
Sponsor listed in the registry: GC Biopharma Corp
- A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fasting ConditionsStatus unknownNCT05703984Phase 1
Sponsor listed in the registry: GC Biopharma Corp
- A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109CompletedNCT01624532Phase 2
Sponsor listed in the registry: Green Cross Corporation
- An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 YearsStatus unknownNCT05664152Not applicable
Sponsor listed in the registry: GC Biopharma Corp
- Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral ImmunodeficiencyCompletedNCT02783482Phase 3
Sponsor listed in the registry: Green Cross Corporation
- A Study of GC3107(BCG Vaccine) in Healthy InfantsCompletedNCT03947138Phase 3
Sponsor listed in the registry: Green Cross Corporation
- A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination ChemotherapyCompletedNCT03454620Phase 1/2
Sponsor listed in the registry: Green Cross Corporation
- A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia PatientsCompletedNCT03855696Phase 1
Sponsor listed in the registry: Green Cross Corporation
- COVIDIG (COVID-19 Hyper-ImmunoGlobulin)CompletedNCT04555148Phase 2
Sponsor listed in the registry: Green Cross Corporation
- A Study of MG1111 in Healthy ChildrenCompletedNCT03375502Phase 2/3
Sponsor listed in the registry: Green Cross Corporation
- Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral ImmunodeficiencyWithdrawnNCT03492710Phase 3
Sponsor listed in the registry: Green Cross Corporation
- Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:CompletedNCT04175522Phase 2
Sponsor listed in the registry: Green Cross Corporation
- Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki DiseaseCompletedNCT04003844Phase 4
Sponsor listed in the registry: Green Cross Corporation
- HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102Status unknownNCT03519113Phase 2/3
Sponsor listed in the registry: Green Cross Corporation
- A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy AdultsStatus unknownNCT04238975Phase 2
Sponsor listed in the registry: Green Cross Corporation
- A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsStatus unknownNCT03801798Phase 2
Sponsor listed in the registry: Green Cross Corporation
- A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy SubjectsCompletedNCT03657719Phase 2
Sponsor listed in the registry: Green Cross Corporation
- A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy AdultsCompletedNCT03357263Phase 1
Sponsor listed in the registry: Green Cross Corporation
- Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy AdultsStatus unknownNCT03363178Phase 1
Sponsor listed in the registry: Green Cross Corporation
- A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsCompletedNCT02569372Phase 1
Sponsor listed in the registry: Green Cross Corporation
- A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of AgeStatus unknownNCT03285997Phase 3
Sponsor listed in the registry: Green Cross Corporation
- A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and OlderCompletedNCT02917304Phase 3
Sponsor listed in the registry: Green Cross Corporation
- Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy AdultsCompletedNCT02367638Phase 1
Sponsor listed in the registry: Green Cross Corporation
- Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) VaccineStatus unknownNCT02813486Phase 1/2
Sponsor listed in the registry: Green Cross Corporation
- A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy ChildrenCompletedNCT02541253Phase 3
Sponsor listed in the registry: Green Cross Corporation
- A Study to Evaluate Efficacy and Safety of GC3110B in Healthy AdultsStatus unknownNCT02915809Phase 3
Sponsor listed in the registry: Green Cross Corporation
- Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid CancerStatus unknownNCT02352571Phase 1
Sponsor listed in the registry: Green Cross Corporation
- A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant RecipientsCompletedNCT02304315Phase 2
Sponsor listed in the registry: Green Cross Corporation
- Evaluate the Safety and Exploratory Efficacy of GC1119CompletedNCT01653444Phase 1
Sponsor listed in the registry: Green Cross Corporation
- An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune ThrombocytopeniaCompletedNCT02063789Phase 3
Sponsor listed in the registry: Green Cross Corporation
- A Prospective Observational Study on Discontinuation of Medication of Shinbaro CapsuleStatus unknownNCT02064634
Sponsor listed in the registry: Green Cross Corporation
- A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III StudyStatus unknownNCT02658409Phase 3
Sponsor listed in the registry: Green Cross Corporation
- Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy AdultStatus unknownNCT02553837Phase 3
Sponsor listed in the registry: Green Cross Corporation
- Study of Idursulfase-beta (GC1111) in Hunter SyndromeStatus unknownNCT02663024Phase 2
Sponsor listed in the registry: Green Cross Corporation
- To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy AdultsCompletedNCT01750814Phase 3
Sponsor listed in the registry: Green Cross Corporation
- Safety Study of MG1102 in Patients With Solid TumorsTerminatedNCT01809912Phase 1
Sponsor listed in the registry: Green Cross Corporation